Edwards Lifesciences Corporation (EW) Q1 2016 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Up 0.8%

Edwards Lifesciences reported a strong EPS performance, exceeding expectations by over 8%. The stock reacted positively, rising by 0.8%. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.71	N/A	+8.23%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized ongoing efforts to address patient needs.

We are pleased with our EPS performance this quarter.

Our focus remains on innovation and meeting patient needs.

Edwards Lifesciences Beats on EPS, Stock Up 0.8%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Up 0.8%

Key numbers

Management commentary